(Q39988241)

16 September 2017

1 reference

title

L-Dopa and Parkinsonism (English)

1 reference

18 March 2023

1 reference

1

Calne DB

1 reference

16 September 2017

M. Sandler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4907560

18 March 2023

language of work or name

English

0 references

publication date

1 April 1970

1 reference

16 September 2017

4 April 1970

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4907560

full work available at URL

18 March 2023

http://www.nature.com/articles/226021a0

1 reference

http://www.nature.com/articles/226021a0.pdf

18 March 2023

file format

Portable Document Format

1 reference

18 March 2023

1 reference

16 September 2017

volume

226

1 reference

16 September 2017

issue

5240

1 reference

16 September 2017

page(s)

21-24

1 reference

https://scigraph.springernature.com/pub.10.1038/226021a0

16 September 2017

exact match

0 references

cites work

Release to the cerebral ventricles of substances with possible transmitter function in the caudate nucleus.

1 reference

The action of dopamine on neurones of the caudate nucleus

21 January 2018

1 reference

Cholinergic mechanisms in the caudate nucleus

21 January 2018

1 reference

Micro-iontophoretic studies on neurones in the cuneate nucleus.

21 January 2018

1 reference

Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine.

21 January 2018

1 reference

Cholinergic-anticholinergic antagonism in parkinsonism.

21 January 2018

1 reference

Multiple electrophoresis peaks of rat liver decarboxylases for 3,4-dihydroxyphenylalanine and 5-hydroxytryptophan

21 January 2018

1 reference

The metabolism of orally administered l-DOPA in Parkinsonism

21 January 2018

1 reference

Drug-Induced Changes of Extracerebral Dopa Metabolism in Man

21 January 2018

1 reference

A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study

21 January 2018

1 reference

Treatment of Parkinsonism With Levodopa

21 January 2018

1 reference

Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).

21 January 2018

1 reference

Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.

21 January 2018

1 reference

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

21 January 2018

1 reference

7 January 2021

On the Occurrence of Homovanillic Acid and 5-Hydroxyindol-3-ylacetic Acid in the Ventricular C.S.F. of Patients Suffering from Parkinsonism

1 reference

7 January 2021

5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.

1 reference

7 January 2021

Metabolism and storage of biogenic amines

1 reference

7 January 2021

In vitro studies on central and peripheral monoamine neurons at the ultrastructural level

1 reference

7 January 2021

INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM

1 reference

7 January 2021

The release of dopamine from the putamen

1 reference

7 January 2021

Caudate unit responses to nigral stimuli: evidence for a possible nigro-neostriatal pathway.

1 reference

7 January 2021

Reciprocal effects on alpha- and gamma-motoneurones of drugs influencing monoaminergic and cholinergic transmission

1 reference

7 January 2021

Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action

1 reference

7 January 2021

The distribution of tryptophan hydroxylase in cat brain

1 reference

7 January 2021

1 reference

7 January 2021

Dopamine (3-Hydroxytyramine) metabolism in parkinsonism

1 reference

7 January 2021

Sustaining life during fulminant hepatic failure

1 reference

7 January 2021

Substrate specificity of brain amine oxidase of several mammals.

1 reference

7 January 2021

Multiple Forms of Human Brain Mitochondrial Monoamine Oxidase

1 reference

7 January 2021

Gas chromatographic measurement of phenolic acids and alcohols in human urine

1 reference

7 January 2021

Further observations on the gas-chromatographic measurement of urinary phenolic and indolic metabolites

1 reference

7 January 2021

m -Hydroxyphenylacetic Acid Formation from L-Dopa in Man: Suppression by Neomycin

1 reference

7 January 2021

The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice

1 reference

7 January 2021

Structure–Activity Relationships of One-Ring Psychotomimetics

1 reference

7 January 2021

Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine

1 reference

7 January 2021

6-hydroxy-dopamine induced degeneration of central monoamine neurons

1 reference

7 January 2021

Hypotension caused by L-dopa

1 reference

7 January 2021

Drug-induced relief of the tremor in monkeys with mesencephalic lesions

1 reference

7 January 2021

Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane

1 reference

7 January 2021

Aromatic Amino Acids and Modification of Parkinsonism

1 reference

7 January 2021

Modification of Parkinsonism--chronic treatment with L-dopa

1 reference

7 January 2021

L-dopa in postencephalitic parkinsonism.

1 reference

7 January 2021

L-dopa in idiopathic parkinsonism.

1 reference

7 January 2021

Effects of L-dopa in Parkinson's disease.

1 reference

7 January 2021

Treatment of Parkinsonism with Laevo-Dopa

1 reference

7 January 2021

Metabolic Studies and Clinical Observations During L-Dopa Treatment of Parkinson's Disease

1 reference

7 January 2021

Selective depletion of caudate nucleus dopamine and serotonin during chronic manganese dioxide administration to squirrel monkeys.

1 reference

7 January 2021

7

11

490

A Carlsson

1959

1 reference

Journal of Pharmacology and Experimental Therapeutics

18 March 2023

13

150

244

FE Bloom

1965

1 reference

18 March 2023

25

18

43

S Udenfriend

1966

1 reference

18 March 2023

Tyrosine Hydroxylase

series ordinal

26

1 reference

18 March 2023

28

18

53

TL Sourkes

1966

1 reference

18 March 2023

33

11

317

P Holtz

1959

1 reference

Journal of Pharmacology and Experimental Therapeutics

18 March 2023

38

161

14

G Bartholini

1968

1 reference

18 March 2023

41

11

350

N Kirshner

1959

1 reference

18 March 2023

Identifiers

DOI

10.1038/226021A0

1 reference

Dimensions Publication ID

16 September 2017

1021869605

0 references

1 reference